Consensus

Airdoc Technology (02251.HK) achieved remarkable success in 2023, accelerating its commercialization in an unparalleled way  

Retrieved on: 
Wednesday, April 10, 2024
Consensus, Glaucoma, Conditional sentence, University, Finance, RMB, Risk, Approximation error, Patient, Artificial intelligence, Medical device, National Health Commission, Optometry, Endocrinology, Dementia, Certification, Hyperthyroidism, Ageing, Capital Medical University, Software, MICCAI, Hypertensive retinopathy, Beijing Tongren Hospital, Neurology, Acceleration, Intelligence, Paratriathlon, Hospital, Research, Near-sightedness, Amblyopia, AI, MDR, Strabismus, Skin, AMD, Ranibizumab, Diagnosis, Peking University, Growth, Cardiology, Physical examination, News, Cataract, Diabetic retinopathy, Ophthalmology

In 2023, Airdoc Technology significantly accelerated its commercialization，while most of its peers were still in the experimental stage or early stages of commercialization.

Key Points: 
  • In 2023, Airdoc Technology significantly accelerated its commercialization，while most of its peers were still in the experimental stage or early stages of commercialization.
  • 2) health risk assessment solutions, covering 55 types of lesions, providing chronic disease management and health assessments for healthcare industry.
  • Airdoc Technology practices the use of AI technology to assist in the prevention and control of myopia among teenagers and the development of eye health.
  • In July 2023, Airdoc Technology participated in the formulation of the "Expert Consensus on Assessing the Risk of Cardiovascular Diseases Using Artificial Intelligence Technology Based on Fundus Images."

BEVM Bitcoin Layer2 Closes Seed Round with RockTree Capital, Sathoshi Lab & 20 Others

Retrieved on: 
Wednesday, March 27, 2024
Consensus, EVM, MAST, Consensus decision-making, Capital, Financial regulation, Architecture, DBFX, BTC, Ecosystem, Traction, Safety, Geography, Cryptocurrency

Singapore, Singapore, March 27, 2024 (GLOBE NEWSWIRE) -- The Bitcoin Layer2 project BEVM has announced the completion of its seed round, and also a part of its Series A round, raising tens of million USD.

Key Points: 
  • Singapore, Singapore, March 27, 2024 (GLOBE NEWSWIRE) -- The Bitcoin Layer2 project BEVM has announced the completion of its seed round, and also a part of its Series A round, raising tens of million USD.
  • BEVM is the first EVM-compatible Bitcoin Layer2 network built on Taproot Consensus and uses $BTC as gas, aiming to bring 10% of $BTC into its Layer2 network environment.
  • Gavin Guo, Core Builder of BEVM said “Taproot Consensus is the final result of our team’s six years of exploring Bitcoin Layer2 solutions.
  • BEVM is currently the most decentralized and secure BTC layer2 solution.”
    BEVM has already implemented decentralized Bitcoin cross-chain custody services through Schnorr Signature, MAST and Bitcoin SPVs.

Mawson Infrastructure Group Expands Co-Location Business

Retrieved on: 
Wednesday, March 27, 2024
Consensus, Douglas Mawson, Miner, Consensus decision-making, Cryptocurrency

MIDLAND, Pa., March 27, 2024 (GLOBE NEWSWIRE) -- Mawson Infrastructure Group Inc. (NASDAQ:MIGI) (“Mawson” or the “Company”), a digital infrastructure company, announced that it has expanded its co-location business.

Key Points: 
  • Expands Enterprise Customer Co-Location Agreement after 3 Consecutive Co-Location Customer Agreements Executed and Implemented since the start of Q4, 2023
    MIDLAND, Pa., March 27, 2024 (GLOBE NEWSWIRE) -- Mawson Infrastructure Group Inc. (NASDAQ:MIGI) (“Mawson” or the “Company”), a digital infrastructure company, announced that it has expanded its co-location business.
  • Rahul Mewawalla, CEO and President, commented, “We are very pleased to increase and grow our co-location services business.
  • The initial Customer Agreement signed on October 12, 2023, between wholly owned subsidiaries of Mawson and Consensus, for co-location business services was approximately 15,876 miners or approximately 50 MW.
  • In addition to its co-location services business, Mawson operates self-mining bitcoin and energy management businesses.

Consensus Cloud Solutions to Host Q1 Investor Call on May 8th, 2024

Retrieved on: 
Monday, April 8, 2024
Technology, Telecommunications, Health Technology, Software, Internet, Health, General Health, Data Management, Artificial Intelligence, Consensus, Cloud, Consensus decision-making, EVP

Consensus Cloud Solutions, Inc., (NASDAQ: CCSI), invites the public, members of the press, the financial community, and other interested parties to listen to a live audio Webcast of its Q1 earnings call at 2:00 PM PT/5:00 PM ET on Wednesday, May 8th, 2024.

Key Points: 
  • Consensus Cloud Solutions, Inc., (NASDAQ: CCSI), invites the public, members of the press, the financial community, and other interested parties to listen to a live audio Webcast of its Q1 earnings call at 2:00 PM PT/5:00 PM ET on Wednesday, May 8th, 2024.
  • Consensus Cloud Solutions’ Chief Executive Officer, Scott Turicchi, Chief Revenue Officer and EVP of Operations, Johnny Hecker, and Chief Financial Officer, Jim Malone will host the call to discuss Q1 financial results, provide an update on the business and host a live Q&A.
  • Questions for the conference call will be taken via email at [email protected] and can be sent any time prior to or during the Webcast.
  • If you are unable to attend the live Webcast, the conference call and presentation materials will be archived at https://www.investor.consensus.com/ .

Bloomberg Launches Point-in-Time Data Solution that Gives Quants a Competitive Edge

Retrieved on: 
Tuesday, April 9, 2024
Consensus, Research, Data, Bias, Estimation, Forward price, Cryptocurrency

NEW YORK, April 9, 2024 /PRNewswire/ -- Bloomberg today announced the launch of Company Financials, Estimates and Pricing Point-in-Time, a new offering that connects and integrates a broad, diverse range of datasets from multiple sources, provides historical point-in-time data and will enable linking traditional company data to more esoteric data like alternative data. The offering aims to reduce challenges associated with going to multiple data providers for the best research data and equipping investors with the data and insights they need to get a competitive edge.

Key Points: 
  • The offering aims to reduce challenges associated with going to multiple data providers for the best research data and equipping investors with the data and insights they need to get a competitive edge.
  • Managing the amount of data that is available today — and gleaning insights not already discovered by the market — has become a massive undertaking," said Tony McManus, Global Head of Enterprise Data at Bloomberg.
  • He added: "By pre-ingesting, mapping and linking many different data sources together, Bloomberg allows customers to significantly reduce the time needed to generate signals or insights.
  • "A critical component of Bloomberg's offering is its inclusion of true, historical point-in-time data, which is essential for accurate backtesting," said Angana Jacob, Head of Research Data, Enterprise Data.

Senator Tillis Kicked off Inaugural Manufacturing & Energy Summit

Retrieved on: 
Monday, April 8, 2024
Consensus, Environment, Natural Resources, Consensus decision-making, Economic development, Quality of life, Super, Investment, Renewable energy

CHARLOTTE, N.C., April 8, 2024 /PRNewswire/ -- Last week, Consensus Digital Media hosted the first-ever Super Charge North Carolina Manufacturing and Energy Summit in Charlotte, NC.

Key Points: 
  • CHARLOTTE, N.C., April 8, 2024 /PRNewswire/ -- Last week, Consensus Digital Media hosted the first-ever Super Charge North Carolina Manufacturing and Energy Summit in Charlotte, NC.
  • Over 100 elected leaders, educators, industry executives, economic development officials, policymakers, and community stakeholders converged on downtown Charlotte.
  • Senator Thom Tillis also echoed this sentiment in his keynote  remarks:
    "I want more of these energy solutions to be based in North Carolina and exported throughout the world and the United States," shared U.S.
  • For highlights from the Super Charge North Carolina Manufacturing & Energy Summit, check out Consensus Digital Media's social channels ( LinkedIn and YouTube ).

Mawson Infrastructure Group Inc. Announces Monthly Operational Update for February 2024

Retrieved on: 
Tuesday, March 19, 2024
Consensus, M/M, Conference, GPU, FTI, Miner, Y/Y, Artificial intelligence, Total, Cryptocurrency

MIDLAND, Pa., March 19, 2024 (GLOBE NEWSWIRE) -- Mawson Infrastructure Group Inc. (NASDAQ:MIGI) (“Mawson” or the “Company”), a digital infrastructure company, announced today its unaudited business and operational update for February 2024.

Key Points: 
  • February Self-Mining Business Revenue up 159% Y/Y and up 23% M/M, about $2.56 million
    February Co-Location Business Revenue about $2.70 million, represents about 62 MW and 19,400 miners
    MIDLAND, Pa., March 19, 2024 (GLOBE NEWSWIRE) -- Mawson Infrastructure Group Inc. (NASDAQ:MIGI) (“Mawson” or the “Company”), a digital infrastructure company, announced today its unaudited business and operational update for February 2024.
  • We are also pleased with the 23% M/M growth in our self-mining business, despite the significant recent increase in network difficulty.
  • Our core operational, technological, and strategic plans continue to advance with our growing role in the industry and our ecosystem.”
    Total monthly revenue increased 141% Y/Y to about $5.42 million and the equivalent of 109 BTC1.
  • Mawson’s Bellefonte facility continues to operate at approximately 8.8 MW of capacity and is used entirely for self-mining purposes.

Hong Kong Successfully Secures the Staging of “Consensus” Conference in Town Next Year with 8,000 Participants to Explore Opportunities in Cryptocurrency and Web 3 Technology in the International Flagship Event

Retrieved on: 
Friday, March 15, 2024
Consensus, HKTB, InvestHK, Fintech, Blockchain, RWA, Financial services, Consensus decision-making, Web3, MICE, CoinDesk, Government, Cryptocurrency

With the Hong Kong Tourism Board (HKTB) support, Consensus, the world’s longest-standing and most influential cryptocurrency and Web 3 event, has announced its staging in Hong Kong from February 19 to 21, 2025 (Consensus Hong Kong 2025).

Key Points: 
  • With the Hong Kong Tourism Board (HKTB) support, Consensus, the world’s longest-standing and most influential cryptocurrency and Web 3 event, has announced its staging in Hong Kong from February 19 to 21, 2025 (Consensus Hong Kong 2025).
  • This is the first time in five years that this influential industry event has been held outside the United States.
  • The event is expected to attract 8,000 participants, of which 6,000 will come from all over the world.
  • At the same time, it will promote exchange between international and local participants through a well-curated programme of activities.

NewAmsterdam Pharma Doses First Patient in Phase 3 TANDEM Clinical Trial Evaluating Fixed-Dose Combination of Obicetrapib and Ezetimibe in Patients with HeFH and/or ASCVD

Retrieved on: 
Tuesday, March 12, 2024
Consensus, Moyamoya disease, Cardiovascular disease, Myocardial infarction, Dyslipidemia, CVD, Cardiology, Risk, Patient, Apolipoprotein B, Consensus decision-making, Stroke, NAMS, ASCVD, Plaque, Artery, Diet, Cleveland Clinic, Ezetimibe, Clinical trial, Safety, FDC, Apolipoprotein, Genetic disorder, Physician, Pharmaceutical industry

NAARDEN, The Netherlands and MIAMI, March 12, 2024 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at risk of cardiovascular disease (“CVD”) with elevated low-density lipoprotein cholesterol (“LDL-C”), for whom existing therapies are not sufficiently effective or well-tolerated, today announced the dosing of the first patient and initiation of TANDEM, a pivotal Phase 3 clinical trial to evaluate obicetrapib and ezetimibe FDC in adult patients with Heterozygous Familial Hypercholesterolemia (“HeFH”) and/or Atherosclerotic Cardiovascular Disease (“ASCVD”) or multiple risk factors for ASCVD, whose LDL-C is not adequately controlled despite being on maximally tolerated lipid-modifying therapies.

Key Points: 
  • The ACC Expert Consensus set LDL-C goals of below the 70mg/dl for patients with ASCVD and below the 55mg/dl goal for ASCVD patients with very high risk.
  • The primary objective of the placebo-controlled, double-blind, four-arm, randomized TANDEM trial is to evaluate the effect of 10mg obicetrapib and 10mg ezetimibe FDC on LDL-C levels, compared to both ezetimibe 10mg and obicetrapib 10mg monotherapy and to placebo.
  • NewAmsterdam anticipates enrolling approximately 400 patients on maximally tolerated lipid-modifying therapies with HeFH, ASCVD or ASCVD risk equivalents and who have a baseline LDL-C of at least 70 mg/Dl.
  • Patients who have multiple risk factors for ASCVD are at high risk of experiencing a cardiovascular event in the near future.

Merz Aesthetics Sponsors Symposium on Global Beauty Landscape and Presents New Insights Around Regenerative Aesthetics at the 2024 Aesthetic and Anti-Aging Medicine World Congress (AMWC)

Retrieved on: 
Thursday, March 21, 2024
Cosmetics, Retail, Medical Devices, Health, Pharmaceutical, Biotechnology, Consensus, Elastin, Visualization, Systematic review, Beauty, Safety, Continent, Patient, Research, Merz, Aesthetics, Doctor of Philosophy, Meta-analysis, Abstract, Congress, Treatment, Trial of the century, Multimedia, Ageing, Medical device

Merz Aesthetics, the world’s largest dedicated medical aesthetics business, is presenting new data for its product portfolio in addition to perspectives on medical aesthetics trends at the 2024 Aesthetic and Anti-Aging Medicine World Congress.

Key Points: 
  • Merz Aesthetics, the world’s largest dedicated medical aesthetics business, is presenting new data for its product portfolio in addition to perspectives on medical aesthetics trends at the 2024 Aesthetic and Anti-Aging Medicine World Congress.
  • AMWC is a leading global scientific conference specializing in aesthetic and anti-aging medicine.
  • Participants can attend live in Monaco or tune in virtually beginning March 27 through March 29, 2024.
  • The abstracts will be available for viewing on-site throughout the congress and displayed on the virtual e-poster platform with detailed abstracts.